Andere Sprachen Kronos Bio, Inc.

Aktien

A2QD64

US50107A1043

KRON

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 18.04.2024			% 5 Tage	% 1. Jan.
1.03 ^USD	-0.96%		-8.85%	-17.60%

21.03.	Kronos Bio, Inc. meldet Ergebnis für das vierte Quartal zum 31. Dezember 2023	CI
21.03.	Kronos Bio, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M	21.03.
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results	21.03.
Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21.03.
Kronos Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21.03.
Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway	07.03.
Kronos Bio, Inc. Announces to Assess KB-0742 At Planned New Dose Schedule in Ongoing Phase 1/2 Study	07.03.
Kronos Bio Plans to Reduction in Force	07.03.
Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting	05.03.
Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference	27.02.
Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference	27.02.
Kronos Bio Announces Management Shakeup, 3 Top Managers to Step Down in February	25.01.
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement	25.01.
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement	25.01.
Kronos Bio, Inc. Announces Executive Changes	25.01.
Investors got more clues that rate cuts are imminent	19.12.
Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate	18.12.
Kronos Bio, Inc. Announces Pipeline Update and p300 KAT Inhibitor Development Candidate	18.12.
Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	04.12.
Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	04.12.
Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference	27.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Kronos Bio, Inc.

Aktien

A2QD64

US50107A1043

KRON

Andere Sprachen

Filter